Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-08-11 Sale |
2023-08-11 4:11 pm |
CHINOOK THERAPEUTICS INC. | KDNY | Thomas Dolca Director |
13,300 | $0 | $0 | 0 (Direct) |
View |
| 2022-09-02 Purchase |
2022-09-06 4:35 pm |
CHINOOK THERAPEUTICS INC. | KDNY | Thomas Dolca Director |
10,000 | $21.22 | $212,194 | 10,000 (Direct) |
View |
| 2020-08-18 Sale |
2020-08-20 8:17 pm |
Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer |
15,000 | $100 | $1,500,000 | 169,883 (Direct) |
View |
| 2020-07-15 Sale |
2020-07-17 8:01 pm |
Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer |
15,000 | $80.07 | $1,201,070 | 184,883 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-05-24 Option Award |
2024-05-29 4:05 pm |
N/A 2034-05-24 |
Allakos Inc. | ALLK | Thomas Dolca Director |
41,000 | $0 | 41,000 (Direct) |
View |
| 2023-08-01 Option Award |
2023-08-03 6:03 pm |
N/A 2033-08-01 |
Allakos Inc. | ALLK | Thomas Dolca Director |
154,786 | $0 | 154,786 (Direct) |
View |
| 2023-05-26 Exercise |
2023-05-31 7:21 pm |
N/A N/A |
CHINOOK THERAPEUTICS INC. | KDNY | Thomas Dolca Director |
3,300 | $0 | 13,300 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-31 6:25 pm |
N/A 2032-05-25 |
CHINOOK THERAPEUTICS INC. | KDNY | Thomas Dolca Director |
16,600 | $0 | 16,600 (Direct) |
View |
| 2021-06-04 Option Award |
2021-06-07 9:38 pm |
N/A 2031-06-03 |
CHINOOK THERAPEUTICS INC. | KDNY | Thomas Dolca Director |
5,948 | $0 | 5,948 (Direct) |
View |
| 2021-01-11 Option Award |
2021-01-13 4:20 pm |
N/A 2031-01-10 |
Equillium Inc. | EQ | Thomas Dolca Chief Medical Officer |
450,000 | $0 | 450,000 (Direct) |
View |
Ownership |
2021-01-13 4:19 pm |
N/A N/A |
Equillium Inc. | EQ | Thomas Dolca Chief Medical Officer |
0 | $0 | 0 (Direct) |
View |
| 2020-10-06 Option Award |
2020-10-07 9:06 pm |
N/A 2030-10-05 |
ADURO BIOTECH INC. | KDNY | Thomas Dolca Director |
23,522 | $0 | 23,522 (Direct) |
View |
| 2020-09-28 Equity Swap |
2020-09-28 5:16 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer |
2,207 | $100 | 0 (Direct) |
View |
| 2020-08-18 Exercise |
2020-08-20 8:17 pm |
N/A 2028-10-22 |
Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer |
15,000 | $0 | 169,883 (Direct) |
View |
| 2020-08-18 Exercise |
2020-08-20 8:17 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer |
15,000 | $23.77 | 169,883 (Direct) |
View |
| 2020-07-15 Exercise |
2020-07-17 8:01 pm |
N/A 2028-10-22 |
Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer |
15,000 | $0 | 184,883 (Direct) |
View |
| 2020-07-15 Exercise |
2020-07-17 8:01 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer |
15,000 | $23.77 | 184,883 (Direct) |
View |